Artgen Biotech PJSC (MIC:ABIO) Change In Inventory : ₽4 Mil (TTM As of Jun. 2023)

View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC Change In Inventory?

Artgen Biotech PJSC's change in inventory for the quarter that ended in Jun. 2023 was ₽6 Mil. It means Artgen Biotech PJSC's inventory declined by ₽6 Mil from Dec. 2022 to Jun. 2023 .

Artgen Biotech PJSC's change in inventory for the fiscal year that ended in Dec. 2022 was ₽16 Mil. It means Artgen Biotech PJSC's inventory declined by ₽16 Mil from Dec. 2021 to Dec. 2022 .

Artgen Biotech PJSC's Total Inventories for the quarter that ended in Jun. 2023 was ₽218 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Artgen Biotech PJSC's Days Inventory for the quarter that ended in Jun. 2023 was 316.42.

Inventory Turnover measures how fast the company turns over its inventory within a year. Artgen Biotech PJSC's Inventory Turnover for the quarter that ended in Jun. 2023 was 0.58.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Artgen Biotech PJSC's Inventory-to-Revenue for the quarter that ended in Jun. 2023 was 0.36.

Artgen Biotech PJSC Change In Inventory Historical Data

The historical data trend for Artgen Biotech PJSC's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artgen Biotech PJSC Change In Inventory Chart

Artgen Biotech PJSC Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Inventory

Get a 7-Day Free Trial

-14.02

-34.80

-106.02

-21.54

16.40

Artgen Biotech PJSC Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Change In Inventory	Get a 7-Day Free Trial															-22.37	0.84	17.87	-1.47	5.81

Artgen Biotech PJSC Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₽4 Mil.

Artgen Biotech PJSC (MIC:ABIO) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Artgen Biotech PJSC's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	220.962	/	127.444	*	365 / 2
	=	316.42

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Artgen Biotech PJSC's Inventory Turnover for the quarter that ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	127.444	/	220.962
	=	0.58

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Artgen Biotech PJSC's Inventory to Revenue for the quarter that ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	220.962	/	621.115
	=	0.36

Artgen Biotech PJSC Change In Inventory Related Terms

Thank you for viewing the detailed overview of Artgen Biotech PJSC's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Artgen Biotech PJSC (MIC:ABIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

Prospect of the 60th Anniversary, Moscow, RUS, 117036

Website

https://www.hsci.ru

Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.